Pessi A - Search Results

1

Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.

Porotto M, Rockx B, Yokoyama CC, Talekar A, Devito I, Palermo LM, Liu J, Cortese R, Lu M, Feldmann H, Pessi A, Moscona A. Porotto M, et al. Among authors: pessi a. PLoS Pathog. 2010 Oct 28;6(10):e1001168. doi: 10.1371/journal.ppat.1001168. PLoS Pathog. 2010. PMID: 21060819 Free PMC article.

2

Viral entry inhibitors targeted to the membrane site of action.

Porotto M, Yokoyama CC, Palermo LM, Mungall B, Aljofan M, Cortese R, Pessi A, Moscona A. Porotto M, et al. Among authors: pessi a. J Virol. 2010 Jul;84(13):6760-8. doi: 10.1128/JVI.00135-10. Epub 2010 Mar 31. J Virol. 2010. PMID: 20357085 Free PMC article.

3

Infection of primary neurons mediated by nipah virus envelope proteins: role of host target cells in antiviral action.

Talekar A, Pessi A, Porotto M. Talekar A, et al. Among authors: pessi a. J Virol. 2011 Aug;85(16):8422-6. doi: 10.1128/JVI.00452-11. Epub 2011 Jun 8. J Virol. 2011. PMID: 21653662 Free PMC article.

4

Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein.

Porotto M, Devito I, Palmer SG, Jurgens EM, Yee JL, Yokoyama CC, Pessi A, Moscona A. Porotto M, et al. Among authors: pessi a. J Virol. 2011 Dec;85(24):12867-80. doi: 10.1128/JVI.05873-11. Epub 2011 Oct 5. J Virol. 2011. PMID: 21976650 Free PMC article.

5

Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus.

Lee KK, Pessi A, Gui L, Santoprete A, Talekar A, Moscona A, Porotto M. Lee KK, et al. Among authors: pessi a. J Biol Chem. 2011 Dec 9;286(49):42141-42149. doi: 10.1074/jbc.M111.254243. Epub 2011 Oct 12. J Biol Chem. 2011. PMID: 21994935 Free PMC article.

6

Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment.

Talekar A, Pessi A, Glickman F, Sengupta U, Briese T, Whitt MA, Mathieu C, Horvat B, Moscona A, Porotto M. Talekar A, et al. Among authors: pessi a. PLoS One. 2012;7(3):e30538. doi: 10.1371/journal.pone.0030538. Epub 2012 Mar 2. PLoS One. 2012. PMID: 22396728 Free PMC article.

7

Fatal measles virus infection prevented by brain-penetrant fusion inhibitors.

Welsch JC, Talekar A, Mathieu C, Pessi A, Moscona A, Horvat B, Porotto M. Welsch JC, et al. Among authors: pessi a. J Virol. 2013 Dec;87(24):13785-94. doi: 10.1128/JVI.02436-13. Epub 2013 Oct 9. J Virol. 2013. PMID: 24109233 Free PMC article.

8

A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity.

Pessi A, Langella A, Capitò E, Ghezzi S, Vicenzi E, Poli G, Ketas T, Mathieu C, Cortese R, Horvat B, Moscona A, Porotto M. Pessi A, et al. PLoS One. 2012;7(5):e36833. doi: 10.1371/journal.pone.0036833. Epub 2012 May 16. PLoS One. 2012. PMID: 22666328 Free PMC article.

9

Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin.

Urbanowicz RA, Lacek K, Lahm A, Bienkowska-Szewczyk K, Ball JK, Nicosia A, Cortese R, Pessi A. Urbanowicz RA, et al. Among authors: pessi a. J Pept Sci. 2015 Sep;21(9):743-9. doi: 10.1002/psc.2802. J Pept Sci. 2015. PMID: 26292842

10

Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure.

Augusto MT, Hollmann A, Castanho MA, Porotto M, Pessi A, Santos NC. Augusto MT, et al. Among authors: pessi a. J Antimicrob Chemother. 2014 May;69(5):1286-97. doi: 10.1093/jac/dkt529. Epub 2014 Jan 23. J Antimicrob Chemother. 2014. PMID: 24464268 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters